Literature DB >> 22054066

Characterization of the human ornithine transcarbamylase 3' untranslated regulatory region.

Monica Lopes-Marques1, Isabel Pereira-Castro, António Amorim, Luisa Azevedo.   

Abstract

Mutations in the untranslated regulatory regions of genes may result in abnormal gene expression or transcriptional regulation. In this study, we characterize the ornithine transcarbamylase (OTC) mRNA isoforms of the X-linked OTC gene involved in the urea formation in the liver. Our data revealed that two major transcripts (OTC-t1 and OTC-t2) are more highly expressed than any of the other isoforms in all the tissues analyzed, though a longer transcript (OTC-t3) was also isolated and characterized from the brain sample. The OTC-t2 sequence fully matches the OTC mRNA reference sequence (NM_000531.5). All three isoforms use a canonical AAUAAA hexamer that is predicted to fold into a hairpin secondary structure which might be exposed to the cleavage and polyadenylation specificity factor. In addition, we observed that the OTC-t1 and OTC-t2 transcripts display heterogeneity at the cleavage sites in a tissue-dependent manner. Taken together, our data demonstrate that several mRNA isoforms are transcribed from the OTC gene, thereby indicating a wide degree of variability in post-transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054066      PMCID: PMC3322402          DOI: 10.1089/dna.2011.1391

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  39 in total

1.  A novel AATAAA-->CATAAA mutation at the polyadenylation site of the beta-globin gene.

Authors:  S K Ma; A C Lee; A Y Chan; L C Chan
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

2.  Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia.

Authors:  N H Gehring; U Frede; G Neu-Yilik; P Hundsdoerfer; B Vetter; M W Hentze; A E Kulozik
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

Review 3.  Urea cycle disorders: diagnosis, pathophysiology, and therapy.

Authors:  S W Brusilow; N E Maestri
Journal:  Adv Pediatr       Date:  1996

4.  Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations.

Authors:  M Giorgi; A Morrone; M A Donati; F Ciani; T Bardelli; G Biasucci; E Zammarchi
Journal:  Hum Mutat       Date:  2000-04       Impact factor: 4.878

5.  A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome.

Authors:  C L Bennett; M E Brunkow; F Ramsdell; K C O'Briant; Q Zhu; R L Fuleihan; A O Shigeoka; H D Ochs; P F Chance
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

6.  The secondary structure of the adenovirus-2 L4 polyadenylation domain: evidence for a hairpin structure exposing the AAUAAA signal in its loop.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  J Mol Biol       Date:  1995-05-05       Impact factor: 5.469

7.  Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: implications for SAGE analysis.

Authors:  E Pauws; A H van Kampen; S A van de Graaf; J J de Vijlder; C Ris-Stalpers
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

8.  Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.

Authors:  Consuelo Climent; Vicente Rubio
Journal:  Hum Mutat       Date:  2002-02       Impact factor: 4.878

9.  Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency.

Authors:  S Balasubramaniam; C Rudduck; B Bennetts; G Peters; B Wilcken; C Ellaway
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

10.  Genetic analysis in nine unrelated Italian patients affected by OTC deficiency: detection of novel mutations in the OTC gene.

Authors:  S Bisanzi; A Morrone; M A Donati; E Pasquini; M Spada; P Strisciuglio; G Parenti; R Parini; F Papadia; E Zammarchi
Journal:  Mol Genet Metab       Date:  2002-06       Impact factor: 4.797

View more
  3 in total

1.  In human brain ornithine transcarbamylase (OTC) immunoreactivity is strongly expressed in a small number of nitrergic neurons.

Authors:  Hans-Gert Bernstein; Hendrik Dobrowolny; Gerburg Keilhoff; Johann Steiner
Journal:  Metab Brain Dis       Date:  2017-09-03       Impact factor: 3.584

2.  Computational pipeline to identify and characterize functional mutations in ornithine transcarbamylase deficiency.

Authors:  R Magesh; C George Priya Doss
Journal:  3 Biotech       Date:  2014-04-24       Impact factor: 2.406

3.  The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.

Authors:  Carmela De Santo; Sarah Booth; Ashley Vardon; Antony Cousins; Vanessa Tubb; Tracey Perry; Boris Noyvert; Andrew Beggs; Margaret Ng; Christina Halsey; Pamela Kearns; Paul Cheng; Francis Mussai
Journal:  Int J Cancer       Date:  2017-12-26       Impact factor: 7.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.